Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)

Clinical trial NCT04774094 · COMPLETED

Trial details

NCT number: NCT04774094
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hospital-Acquired Pneumonia

Start date: 2021-05-21
Primary completion: 2023-05-04
Enrollment: 235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.